CASE STUDY: Within large biopharma organizations, there are huge duplications of effort and significant overlap of spend. This also occurs within the sales and medical affairs training initiatives. This common practice in larger organizations is also an environment in which consistency and quality of training, currency and accuracy of training, as well as global sustainability of training platforms can be called into question.
AMGEN Pharmaceuticals has recently sought to break down the wall between medical affairs training and commercial training; acknowledging the distinct regulatory treatment differences, but seeking common ground on training content and delivery to create significant efficiencies and improvements in cost, quality, consistency, and delivery.
This case study discussion will enable the attendee to evaluate their own internal needs and capabilities within their own organization and seek to apply similar considerations and criteria potentially leading to higher efficiency and more effective training platforms which can leverage common content and technology while meeting the needs and complexity of contemporary sales and medical affairs teams.